The relationship of antihypertensive drugs have a long history of asso
ciation with sexual dysfunction; however, this relationship is poorly
documented. There appears to be a higher rate of sexual dysfunction in
untreated hypertensive men compared with normotensive men. Sexual dys
function increases with age and is associated with physical and emotio
nal symptoms. There are few studies assessing sexual dysfunction with
female and African-American hypertensive patients. Sexual dysfunction
is associated with impairment of quality of life and noncompliance. Si
nce group data may hide individual drug effects, baseline data should
be collected on all patients before initiating therapy with any antihy
pertensive agent. Although questionnaires may not provide objective in
formation on sexual dysfunction, the response rate to direct questioni
ng may be less than the response rate on a questionnaire and may be af
fected by the gender or race of the interviewer. Research protocols us
ing a double-blind, placebo-controlled design should assess sexual dys
function in men and women in a standardized fashion.